Anticipating Demand for Emergency Health Services due to Medication-related Adverse Events after Rapid Mass Prophylaxis Campaigns

Academic Emergency Medicine

Volumn 14, Issue 3, 2007, Pages 268-274

  Hupert, Nathaniel ^a   Wattson, Daniel ^a   Cuomo, Jason ^a   Benson, Samuel ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

bioterrorism; emergency treatment; hospital bed capacity; mass immunization; risk management

Indexed keywords

ANTHRAX VACCINE; CIPROFLOXACIN; DOXYCYCLINE; SMALLPOX VACCINE;

ANTHRAX; ARTICLE; BIOLOGICAL WARFARE; CALCULATION; CHEMOPROPHYLAXIS; COMMUNITY CARE; COMPUTER MODEL; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; EMERGENCY WARD; HEALTH CARE; HEALTH CARE PLANNING; HOSPITAL BED CAPACITY; HOSPITALIZATION; HUMAN; MASS IMMUNIZATION; MYOCARDITIS; PRIORITY JOURNAL; RISK MANAGEMENT; SMALLPOX; UNSPECIFIED SIDE EFFECT;

ANTHRAX; ANTHRAX VACCINES; CHEMOPREVENTION; DISEASE OUTBREAKS; EMERGENCY MEDICAL SERVICES; HUMANS; MODELS, THEORETICAL; NEEDS ASSESSMENT; SMALLPOX; SMALLPOX VACCINE; UNITED STATES;

EID: 33847187719     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2006.08.017     Document Type: Article

References (32)

1. Henderson D.A., Inglesby T.V., Bartlett J.G., et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281 (1999) 2127-2137
2. Radovanovic Z., and Djordjevic Z. Mass vaccination against smallpox and mortality in Yugoslavia in 1972. [letter]. Trans R Soc Trop Med Hyg 73 1 (1979) 122
3. Thomson D. Mass immunization in the control of infectious disease. Br Med J 5511 (1966) 427-433
4. Wharton M., Strikas R.A., Harpaz R., et al. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52 RR-7 (2003) 1-16
5. Bozzette S.A., Boer R., Bhatnagar V., et al. A model for a smallpox-vaccination policy. N Engl J Med 348 (2003) 416-425
6. Halloran M.E., Longini Jr. I.M., Nizam A., and Yang Y. Containing bioterrorist smallpox. Science Online 298 (2002) 1428-1432
7. Kaplan E.H., Craft D.L., and Wein L.M. Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci U S A 99 (2002) 10935-10940
8. Centers for Disease Control and Prevention. CDC Strategic National Stockpile, 2004. Key Facts about the Cities Readiness Initiative Pilot Program. Press Release. Available at: http://www.bt.cdc.gov/cri/facts.asp. Accessed Nov 10, 2005.
9. Kemper A.R., Davis M.M., and Freed G.L. Expected adverse events in a mass smallpox vaccination campaign. Eff Clin Pract 5 2 (2002) 84-90
10. Gopalan T., and Ghosh B. Poisson distribution in the determination of hospital needs. Indian J Public Health 10 3 (1966) 105-109
11. Baggs J., Chen R.T., Damon I.K., et al. Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program. Clin Infect Dis 40 (2005) 1133-1140
12. Wollenberg A., and Engler R. Smallpox, vaccination and adverse reactions to smallpox vaccine. Curr Opin Allergy Clin Immunol 4 (2004) 271-275
13. Vellozzi C., Averhoff F., Lane J.M., et al. Superinfection following smallpox vaccination (vaccinia), United States: surveillance January 2003 through January 2004. Clin Infect Dis 39 (2004) 1660-1666
14. Talbot T.R., Stapleton J.T., Brady R.C., et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 292 (2004) 1205-1212
15. Orr N., Forman M., Marcus H., et al. Clinical and immune responses after revaccination of Israeli adults with the Lister strain of vaccinia virus. J Infect Dis 190 (2004) 1295-1302
16. Fillmore G.L., Ward T.P., Bower K.S., et al. Ocular complications in the Department of Defense Smallpox Vaccination Program. Ophthalmology 111 (2004) 2086-2093
17. Eckart R.E., Love S.S., Atwood J.E., et al. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol 44 (2004) 201-205
18. Cassimatis D.C., Atwood J.E., Engler R.M., Linz P.E., Grabenstein J.D., and Vernalis M.N. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol 43 (2004) 1503-1510
19. Arness M.K., Eckart R.E., Love S.S., et al. Myopericarditis following smallpox vaccination. Am J Epidemiol 160 (2004) 642-651
20. Centers for Disease Control and Prevention. Secondary and tertiary transfer of vaccinia virus among U.S. military personnel-United States and worldwide, 2002-2004. MMWR Morb Mortal Wkly Rep 53 5 (2004) 103-105
21. Halsell J.S., Riddle J.R., Atwood J.E., et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 289 (2003) 3283-3289
22. Grabenstein J.D., and Winkenwerder Jr. W. US military smallpox vaccination program experience. JAMA 289 (2003) 3278-3282
23. Aragon T.J., and Fernyak S.E. The risks and benefits of pre-event smallpox vaccination: where you stand depends on where you sit. Ann Emerg Med 42 (2003) 681-684
24. Centers for Disease Control and Prevention. Cardiac adverse events following smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 52 12 (2003) 248-250
25. Centers for Disease Control and Prevention. Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 52 13 (2003) 282-284
26. Centers for Disease Control and Prevention. Update: cardiac and other adverse events following civilian smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 52 27 (2003) 639-642
27. Centers for Disease Control and Prevention. Update: adverse events following civilian smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 52 34 (2003) 819-820
28. Shepard C.W., Soriano-Gabarro M., Zell E.R., et al. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerg Infect Dis 8 (2002) 1124-1132
29. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 2001 Emergency Department Summary. Advance Data 335. Hyattsville, MD: National Center for Health Statistics, Jun 4, 2003. Available at: http://www.cdc.gov/nchs/data/ad/ad335.pdf. Accessed Aug 14, 2005.
30. Marghella P. Medical planning considerations in consequence management. Front Health Serv Manage 19 1 (2002) 15-23
31. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 353 (2005) 1363-1373
32. Hupert N, Cuomo J, Callahan MA, Mushlin AI, Morse SS. Community-Based Mass Prophylaxis: A Planning Guide for Public Health Preparedness. Prepared by Weill Medical College of Cornell University, Department of Public Health under Contract No. 290-02-0013-3. AHRQ Pub No. 04-0044. Rockville, MD: Agency for Healthcare Research and Quality, Aug 2004.